The vaccine guarantees one protection from the Covid “Protracted over time”. The second report prepared by the ‘Covid-19 vaccine surveillance’ working group of Higher Institute of Health (Iss) and the Ministry of Health confirms the effectiveness of vaccination in the fight against coronavirus: thanks to the most recent data, it was possible to verify that after 105-112 days from the first dose “we observe a further reduction of risk of diagnosis“.
The data communicated by the ISS confirm what emerged in the first report of last May 15: “The risks of infection with Sars-CoV-2, hospitalization, admission to intensive care and death they decrease rapidly“In people vaccinated against Covid-19,” after the first two weeks and up to about 35 days from the administration of the first dose “. After 35 days, one is observed stabilization of this reduction which is approximately80% for the risk of diagnosis, the 90% for the risk of recovery and ICU admission and the 95% for the risk of death“.
This second report also analyzes the effects on long period, which in mid-May it was still not possible to verify. “From 105-112 days after vaccination, a further reduction risk of diagnosis, with a similar effect in men, women and people in different age groups. There are currently no increases in the risk of diagnosis during the observation periods longer after vaccination, this suggests a protracted protection over time ”, highlights the report. Which also confirms how the effects of vaccines are “similar both in the men than in women and in different people age group. Similar reductions in hospitalization are also observed for healthcare workers and guests of the RSA ”.
The new report, reported about 14 million people vaccinated with at least one dose, it comes to an evaluation a over 130 days from the administration of the first dose. Compared to the previous report, the number of vaccinated subjects in the age group from 40 years and up and there is an increase in vaccinations with Comirnaty (Pfizer/BioNTech) e Vaxzevria (AstraZeneca) and the start of vaccine administrations Janssen (Johnson&Johnson).
Support ilfattoquotidiano.it: if you believe in our battles, fight with us!
Supporting ilfattoquotidiano.it means two things: allowing us to continue publishing an online newspaper full of news and insights, free for all. But also being an active part of a community and doing your part to carry on together the battles we believe in with ideas, testimonies and participation. Your contribution is essential. Support now